Gene · 1284
Papers2,425
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,425
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intracerebral haemorrhage associated with collagen type IV alpha 2 gene mutation and familial small vessel disease. | BMJ Case Rep | 2026 | 42103335 | PubTator, text mining | PubMed |
| Stratification of Phenotypes in Childhood-Onset COL4A1/COL4A2-Related Disorders Based on Age of Presentation. | Neurol Genet | 2026 | 42099677 | PubTator, text mining | PubMed |
| Internal carotid and vertebrobasilar artery dolichoectasia in patients with cerebral small vessel disease and COL4A1/COL4A2 duplication. | Neurogenetics | 2026 | 42065832 | PubTator, text mining | PubMed |
| Multi omics and mechanistic investigation reveals CBFB as a prognostic biomarker in gastric cancer. | Discov Oncol | 2026 | 42056631 | PubTator, text mining | PubMed |
| Genetic determinants of childhood blood pressure and heart rate in relation to adult health outcomes: the consortium of childhood blood pressure. | Eur Heart J | 2026 | 42036355 | PubTator, text mining | PubMed |
| Fatal hemorrhagic transformation following recurrent cerebral infarction in adult-onset cerebral small vessel disease matching the COL4A1/COL4A2 duplication phenotype. | Acta Neurol Belg | 2026 | 42020642 | PubTator, text mining | PubMed |
| Correspondence on "COL4A1 and COL4A2-related disorders: Clinical features, diagnostic guidelines, and management" by Tambala et al. | Genet Med | 2026 | 41964655 | PubTator, text mining | PubMed |
| Comparative omics reveals conserved extracellular matrix signatures during mammary tumor progression. | Front Oncol | 2026 | 41952687 | PubTator, text mining | PubMed |
| Peptide p[63-82] induces transcriptomic alterations associated with processes involved in cartilage repair in osteoarthritic human chondrocytes. | Connect Tissue Res | 2026 | 41943978 | PubTator, text mining | PubMed |
| Gene Expression Alterations Associated With Resveratrol-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Osteosarcoma Cancer Cells. | J Cell Mol Med | 2026 | 41937498 | PubTator, text mining | PubMed |
| Selective vulnerability of cerebral vasculature to NOTCH3 variants in small vessel disease and rescue by phosphodiesterase-5 inhibitor. | Sci Adv | 2026 | 41931622 | PubTator, text mining | PubMed |
| Spontaneous atraumatic pediatric basal ganglia hemorrhage in the setting of COLGALT1-related collagenopathy: illustrative case. | J Neurosurg Case Lessons | 2026 | 41911597 | PubTator, text mining | PubMed |
| African Swine Fever Virus R238L and R298L Disrupt Lung Cell Collagen Formation and Cell Adhesion Pathway by Targeting Transcription Factors Containing zf-C2H2 Domain. | Vet Sci | 2026 | 41893653 | PubTator, text mining | PubMed |
| Protein co-expression network analysis explores biological mechanisms associated with meat quality variability in broilers affected by breast myopathies: A focus on wooden breast. | Poult Sci | 2026 | 41887176 | PubTator, text mining | PubMed |
| FGFR signaling establishes spatial gradients of secretory cell identities along the airway proximal-distal axis. | Nat Commun | 2026 | 41851103 | PubTator, text mining | PubMed |
| Testing the performance of polygenic scores for multiple traits to explain cerebral palsy in two independent cohorts. | EBioMedicine | 2026 | 41833578 | PubTator, text mining | PubMed |
| Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation. | World J Hepatol | 2026 | 41809472 | PubTator, text mining | PubMed |
| COL4A1/COL4A2 gene duplication causing hereditary cerebral small vessel disease in a Chinese patient. | Acta Neurol Belg | 2026 | 41784710 | PubTator, text mining | PubMed |
| Single-cell multi-omics analysis of the tumour microenvironment for colorectal cancer liver metastasis. | Clin Transl Med | 2026 | 41781365 | PubTator, text mining | PubMed |
| Enhanced antitumor efficacy of combined targeting of adenosine A2B receptor and PD-1 is mediated via multiple effects on different cell populations within tumor microenvironment. | Cancer Immunol Immunother | 2026 | 41762251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1284/papers?page=2